Abeona Therapeutics (ABEO) Debt to Equity (2016 - 2025)
Abeona Therapeutics (ABEO) has 11 years of Debt to Equity data on record, last reported at $0.12 in Q3 2025.
- For Q3 2025, Debt to Equity fell 71.69% year-over-year to $0.12; the TTM value through Sep 2025 reached $0.12, down 71.69%, while the annual FY2024 figure was $0.43, N/A changed from the prior year.
- Debt to Equity reached $0.12 in Q3 2025 per ABEO's latest filing, down from $0.12 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.72 in Q3 2022 and bottomed at -$2.04 in Q1 2024.
- Average Debt to Equity over 4 years is $0.2, with a median of $0.36 recorded in 2021.
- Peak YoY movement for Debt to Equity: skyrocketed 2228.66% in 2021, then crashed 71.69% in 2025.
- A 4-year view of Debt to Equity shows it stood at $0.2 in 2021, then decreased by 21.79% to $0.16 in 2022, then soared by 176.85% to $0.43 in 2024, then crashed by 73.22% to $0.12 in 2025.
- Per Business Quant database, its latest 3 readings for Debt to Equity were $0.12 in Q3 2025, $0.12 in Q2 2025, and $0.47 in Q1 2025.